• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

现代放射治疗技术:在中低收入国家获取的障碍和机遇。

Modern Radiotherapy Technology: Obstacles and Opportunities to Access in Low- and Middle-Income Countries.

机构信息

Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India.

Homi Bhabha National Institute, Mumbai, India.

出版信息

JCO Glob Oncol. 2022 Jul;8:e2100376. doi: 10.1200/GO.21.00376.

DOI:10.1200/GO.21.00376
PMID:35839434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9812473/
Abstract

Low- and middle-income countries (LMICs) have a large burden of cancer with differential population needs and outcomes compared to high-income countries. Access to radiotherapy, especially modern technology, is a major challenge. Modern radiotherapy has been demonstrated with better utility in overall cancer outcomes. We deliberate various challenges and opportunities unique to LMICs' set up for access to modern radiotherapy technology in the light of discussions and deliberations made during the recently concluded annual meeting of Tata Memorial Centre, India. We take examples available from various LMICs in this direction in our manuscript.

摘要

中低收入国家(LMICs)的癌症负担沉重,与高收入国家相比,其人口需求和结果存在差异。获得放射治疗的机会,特别是现代技术,是一个主要挑战。现代放射治疗在整体癌症结果方面表现出更好的效果。根据印度塔塔纪念中心最近举行的年度会议上的讨论和审议,我们针对中低收入国家获得现代放射治疗技术的独特挑战和机遇进行了审议。在本文中,我们举了来自不同中低收入国家的例子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b0/9812473/b3e696972b2e/go-8-e2100376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b0/9812473/b3e696972b2e/go-8-e2100376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b0/9812473/b3e696972b2e/go-8-e2100376-g003.jpg

相似文献

1
Modern Radiotherapy Technology: Obstacles and Opportunities to Access in Low- and Middle-Income Countries.现代放射治疗技术:在中低收入国家获取的障碍和机遇。
JCO Glob Oncol. 2022 Jul;8:e2100376. doi: 10.1200/GO.21.00376.
2
Development of the 'REadiness SElf-assessment (RESEA) guide' to assist low and middle-income countries with establishing safe and sustainable radiotherapy services: a pragmatic sequential mixed qualitative methods project.制定“准备情况自我评估(RESEA)指南”以协助低收入和中等收入国家建立安全且可持续的放射治疗服务:一项务实的序贯混合定性方法项目
BMC Health Serv Res. 2021 Mar 23;21(1):268. doi: 10.1186/s12913-021-06274-x.
3
The Benefits of Providing External Beam Radiotherapy in Low- and Middle-income Countries.在低收入和中等收入国家提供外照射放疗的益处。
Clin Oncol (R Coll Radiol). 2017 Feb;29(2):72-83. doi: 10.1016/j.clon.2016.11.003. Epub 2016 Dec 1.
4
Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities.通过新型放射治疗研究机会应对中低收入国家的挑战。
Lancet Oncol. 2024 Jun;25(6):e270-e280. doi: 10.1016/S1470-2045(24)00038-X.
5
Challenges facing the urologist in low- and middle-income countries.中低收入国家泌尿科医生面临的挑战。
World J Urol. 2020 Nov;38(11):2987-2994. doi: 10.1007/s00345-020-03101-6. Epub 2020 Feb 7.
6
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries.改善中低收入国家获得负担得起的、有质量保证的吸入性药物的途径。
Int J Tuberc Lung Dis. 2022 Nov 1;26(11):1023-1032. doi: 10.5588/ijtld.22.0270.
7
Radiotherapy in small countries.小国的放射治疗。
Cancer Epidemiol. 2017 Oct;50(Pt B):257-259. doi: 10.1016/j.canep.2017.06.007.
8
Surveying the Challenges to Improve Linear Accelerator-based Radiation Therapy in Africa: a Unique Collaborative Platform of All 28 African Countries Offering Such Treatment.调查改善非洲基于线性加速器的放射治疗所面临的挑战:一个独特的协作平台,涵盖了所有提供此类治疗的 28 个非洲国家。
Clin Oncol (R Coll Radiol). 2021 Dec;33(12):e521-e529. doi: 10.1016/j.clon.2021.05.008. Epub 2021 Jun 9.
9
Access to environmental health assets across wealth strata: Evidence from 41 low- and middle-income countries.环境健康资产在各财富阶层间的可及性:来自 41 个低收入和中等收入国家的证据。
PLoS One. 2018 Nov 16;13(11):e0207339. doi: 10.1371/journal.pone.0207339. eCollection 2018.
10
Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact.在低收入和中等收入国家普及人乳头瘤病毒疫苗时代宫颈癌放射治疗的推广:基于模型的需求和经济影响分析。
Lancet Oncol. 2019 Jul;20(7):915-923. doi: 10.1016/S1470-2045(19)30308-0. Epub 2019 May 28.

引用本文的文献

1
Management of patients with cancer pain: an evaluation of AGREE II-based clinical practice guidelines.癌症疼痛患者的管理:基于AGREE II的临床实践指南评估
Support Care Cancer. 2025 Aug 14;33(9):785. doi: 10.1007/s00520-025-09799-7.
2
Institutional management factors influencing compliance with National Cancer Treatment Guidelines for cervical cancer: a case study from ocean road cancer institute, Tanzania.影响宫颈癌国家癌症治疗指南依从性的机构管理因素:来自坦桑尼亚海洋路癌症研究所的案例研究
BMC Cancer. 2025 Aug 2;25(1):1259. doi: 10.1186/s12885-025-14702-y.
3
Improving Access to Radiotherapy in Gauteng: A Framework for Equitable Cancer Care.

本文引用的文献

1
Curative-Intent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck in Sri Lanka: The Impact of Radiotherapy Technique on Survival.斯里兰卡头颈部鳞状细胞癌的根治性放疗:放疗技术对生存的影响。
Clin Oncol (R Coll Radiol). 2021 Dec;33(12):765-772. doi: 10.1016/j.clon.2021.09.017. Epub 2021 Oct 9.
2
Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial.辅助常规放疗与图像引导调强放疗治疗宫颈癌(PARCER)的晚期毒性:一项随机对照试验。
J Clin Oncol. 2021 Nov 20;39(33):3682-3692. doi: 10.1200/JCO.20.02530. Epub 2021 Sep 10.
3
改善豪登省放疗服务的可及性:公平癌症护理框架
Int J Environ Res Public Health. 2025 Jul 3;22(7):1071. doi: 10.3390/ijerph22071071.
4
A Feasibility Study for Clinical Implementation of hypo fractionated SBRT Program at a Clinic in an LMIC Using Locally Designed Lung Phantom.在中低收入国家一家诊所使用本地设计的肺部体模对低分割立体定向放疗计划进行临床实施的可行性研究。
Adv Radiat Oncol. 2025 Mar 7;10(6):101752. doi: 10.1016/j.adro.2025.101752. eCollection 2025 Jun.
5
Availability of radiation therapy facilities in Iran in a global context.全球背景下伊朗放射治疗设施的可及性。
BMC Glob Public Health. 2025 May 1;3(1):35. doi: 10.1186/s44263-025-00154-w.
6
Improving Access to Radiotherapy: Exploring Structural Quality Indicators for Radiotherapy in Gauteng Province, South Africa.改善放疗可及性:探索南非豪登省放疗的结构质量指标
Int J Environ Res Public Health. 2025 Apr 8;22(4):585. doi: 10.3390/ijerph22040585.
7
Training for tomorrow: Establishing a worldwide curriculum in online adaptive radiation therapy.为明天而培训:建立全球在线自适应放射治疗课程体系
Tech Innov Patient Support Radiat Oncol. 2025 Feb 5;33:100304. doi: 10.1016/j.tipsro.2025.100304. eCollection 2025 Mar.
8
The Relationship Between Travel Distance for Treatment and Outcomes in Patients Undergoing Radiation Therapy: A Systematic Review.放疗患者治疗行程距离与治疗结果之间的关系:一项系统综述
Adv Radiat Oncol. 2024 Oct 9;9(12):101652. doi: 10.1016/j.adro.2024.101652. eCollection 2024 Dec.
9
An Analysis of Radiotherapy Machine Requirements in India: Impact of the Pandemic and Regional Disparities.印度放射治疗设备需求分析:疫情影响与地区差异
J Med Phys. 2024 Jul-Sep;49(3):370-378. doi: 10.4103/jmp.jmp_20_24. Epub 2024 Sep 21.
10
Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control.回顾过去,展望未来:全球宫颈癌预防与控制的挑战与机遇。
Viruses. 2024 Aug 25;16(9):1357. doi: 10.3390/v16091357.
Radiotherapy resources in Africa: an International Atomic Energy Agency update and analysis of projected needs.
非洲放射治疗资源:国际原子能机构的最新情况和对预计需求的分析。
Lancet Oncol. 2021 Sep;22(9):e391-e399. doi: 10.1016/S1470-2045(21)00351-X.
4
A prospective study to determine the cost of illness for oral cancer in India.一项确定印度口腔癌疾病成本的前瞻性研究。
Ecancermedicalscience. 2021 Jun 17;15:1252. doi: 10.3332/ecancer.2021.1252. eCollection 2021.
5
Cost-effectiveness of treating head and neck cancer using intensity-modulated radiation therapy: implications for cancer control program in India.头颈部癌症调强放射治疗的成本效益:对印度癌症控制规划的启示。
Int J Technol Assess Health Care. 2020 Oct;36(5):492-499. doi: 10.1017/S0266462320000677. Epub 2020 Sep 23.
6
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial.立体定向消融放疗在寡转移癌综合治疗中的应用:SABR-COMET Ⅱ期随机试验的长期结果。
J Clin Oncol. 2020 Sep 1;38(25):2830-2838. doi: 10.1200/JCO.20.00818. Epub 2020 Jun 2.
7
Can the Adoption of Hypofractionation Guidelines Expand Global Radiotherapy Access? An Analysis for Breast and Prostate Radiotherapy.采用大分割放疗指南能否扩大全球放疗可及性?一项针对乳腺癌和前列腺癌放疗的分析。
JCO Glob Oncol. 2020 Apr;6:667-678. doi: 10.1200/JGO.19.00261.
8
Provision and use of radiotherapy in Europe.欧洲放射治疗的供应与使用。
Mol Oncol. 2020 Jul;14(7):1461-1469. doi: 10.1002/1878-0261.12690. Epub 2020 May 1.
9
Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL).一项比较中危和高危伴淋巴结转移前列腺癌患者采用中度和大分割放疗的随机对照临床试验方案(PRIME TRIAL)。
BMJ Open. 2020 Feb 28;10(2):e034623. doi: 10.1136/bmjopen-2019-034623.
10
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study.与标准放疗相比,调强放疗(IMRT)改善患者报告结局:NRG 肿瘤学 RTOG 1203 研究报告。
J Clin Oncol. 2020 May 20;38(15):1685-1692. doi: 10.1200/JCO.19.02381. Epub 2020 Feb 19.